Skip to content

Reported August 7, 2025 · After market close

Revenue estimate$55.5M
EPS estimate-$0.10

Next report

Aug 6, 2026 (in a month)
Revenue estimate$80.1M
EPS estimate$0.05

Financials

Q2 2025

Income statement

See full
Revenue$61.4M+48.9%
Gross profit$40.3M+62.3%
Operating income-$4.3M+56.7%
Net income-$5.3M+50.3%
EPS (diluted)-$0.24+82.9%

Balance sheet

See full
Cash & equivalents$223.1M+165%
Total debt$30.0M
Total equity$214.2M+157%
Total assets$303.0M

Cash flow

See full
CapEx$271.0K

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$893.22M
Enterprise value$700.04M
P/S4.3×

Profitability

See full
Gross margin63.3%+7.3pp
Operating margin-13.5%-5.5pp
Net margin-15.4%-6.1pp

Returns & leverage

See full
Debt / equity0.1×
Current ratio4.7×

Segments

By product

See full
Services$57.0M+48.5%
Hardware$4.4M+54.2%

By segment

See full
Reportable Segment$61.4M+48.9%

Versus estimates

Ask the moment Omada Health, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Omada Health, Inc. Common Stock report Q2 2025 earnings?
Omada Health, Inc. Common Stock (OMDA) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Omada Health, Inc. Common Stock's Q2 2025 revenue and EPS?
Omada Health, Inc. Common Stock reported revenue of $61.4M and diluted EPS of $-0.09 for Q2 2025.
Did Omada Health, Inc. Common Stock beat estimates in Q2 2025?
Revenue beat the consensus estimate of $55.5M by $5.9M. EPS beat the consensus estimate of $-0.10 by $0.01.
Where can I find Omada Health, Inc. Common Stock's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001611115-25-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.